BioCentury | Apr 8, 2020
Finance

Suzhou Ribo raises $66.3M for nucleic acid therapies

...continue to develop SR061 for NA-AION. Ribo and Quark Pharmaceuticals Inc. formed the joint venture Kunshan RiboQuark Pharmaceutical Technology Co. Ltd....
BioCentury | Nov 9, 2015
Clinical News

QPI-1007: Phase II/III started

...a single intravitreal injection or as 3 injections 2 months apart in about 352 patients. RiboQuark...
...and other undisclosed markets (see BioCentury, Dec. 23, 2013). Biocon Ltd. (NSE:BIOCON; BSE:BIOCON), Bangalore, India Kunshan RiboQuark Pharmaceutical Technology Co. Ltd....
BioCentury | Jul 24, 2014
Cover Story

It is an RNA world

...agriculture Up to $86.2 million Jan. 13 Kunshan RiboQuark Pharmaceutical Technology Co. Ltd....
...GJA1; CX43; connexin-43) Phase II Optic neuropathy Kunshan RiboQuark Pharmaceutical Technology Co. Ltd....
BioCentury | Jul 21, 2014
Clinical News

QPI-1007: Phase IIa started

...injections of 1.5 mg QPI-1007 in about 60 patients with unilateral acute primary angle-closure glaucoma. RiboQuark...
...which produces synthetic oligonucleotides. Biocon Ltd. (NSE:BIOCON; BSE:BIOCON), Bangalore, India BioSpring GmbH , Frankfurt, Germany Kunshan RiboQuark Pharmaceutical Technology Co. Ltd....
BioCentury | May 15, 2014
Distillery Therapeutics

Indication: Neurology

...by chronic stress. Next steps include screening for compounds that disrupt the effect of REDD1. Kunshan RiboQuark Pharmaceutical Technology Co. Ltd....
BioCentury | Jan 13, 2014
Financial News

RiboQuark completes venture financing

...Kunshan RiboQuark Pharmaceutical Technology Co. Ltd. , Kunshan, China Business: Ophthalmic Date completed: 1/7/14 Type: Venture...
...Incubation; Kunshan Industrial Technology Research Institute Investment; Kunshan Hongtu Hi-tech Venture Capital Management Note: Kunshan RiboQuark...
BioCentury | Jan 8, 2014
Financial News

RiboQuark raises $7.4 million in A round

...Kunshan RiboQuark Pharmaceutical Technology Co. Ltd. (Kunshan, China) raised almost RMB45 million ($7.4 million) in a...
...Kunshan Industrial Technology Research Institute Investment; and Kunshan Hongtu Hi-tech Venture Capital Management also participated. RiboQuark...
...between RNAi companies Suzhou Ribo Life Sciences Co. Ltd. (Kunshan, China) and Quark Pharmaceuticals Inc. RiboQuark's...
Items per page:
1 - 7 of 7
BioCentury | Apr 8, 2020
Finance

Suzhou Ribo raises $66.3M for nucleic acid therapies

...continue to develop SR061 for NA-AION. Ribo and Quark Pharmaceuticals Inc. formed the joint venture Kunshan RiboQuark Pharmaceutical Technology Co. Ltd....
BioCentury | Nov 9, 2015
Clinical News

QPI-1007: Phase II/III started

...a single intravitreal injection or as 3 injections 2 months apart in about 352 patients. RiboQuark...
...and other undisclosed markets (see BioCentury, Dec. 23, 2013). Biocon Ltd. (NSE:BIOCON; BSE:BIOCON), Bangalore, India Kunshan RiboQuark Pharmaceutical Technology Co. Ltd....
BioCentury | Jul 24, 2014
Cover Story

It is an RNA world

...agriculture Up to $86.2 million Jan. 13 Kunshan RiboQuark Pharmaceutical Technology Co. Ltd....
...GJA1; CX43; connexin-43) Phase II Optic neuropathy Kunshan RiboQuark Pharmaceutical Technology Co. Ltd....
BioCentury | Jul 21, 2014
Clinical News

QPI-1007: Phase IIa started

...injections of 1.5 mg QPI-1007 in about 60 patients with unilateral acute primary angle-closure glaucoma. RiboQuark...
...which produces synthetic oligonucleotides. Biocon Ltd. (NSE:BIOCON; BSE:BIOCON), Bangalore, India BioSpring GmbH , Frankfurt, Germany Kunshan RiboQuark Pharmaceutical Technology Co. Ltd....
BioCentury | May 15, 2014
Distillery Therapeutics

Indication: Neurology

...by chronic stress. Next steps include screening for compounds that disrupt the effect of REDD1. Kunshan RiboQuark Pharmaceutical Technology Co. Ltd....
BioCentury | Jan 13, 2014
Financial News

RiboQuark completes venture financing

...Kunshan RiboQuark Pharmaceutical Technology Co. Ltd. , Kunshan, China Business: Ophthalmic Date completed: 1/7/14 Type: Venture...
...Incubation; Kunshan Industrial Technology Research Institute Investment; Kunshan Hongtu Hi-tech Venture Capital Management Note: Kunshan RiboQuark...
BioCentury | Jan 8, 2014
Financial News

RiboQuark raises $7.4 million in A round

...Kunshan RiboQuark Pharmaceutical Technology Co. Ltd. (Kunshan, China) raised almost RMB45 million ($7.4 million) in a...
...Kunshan Industrial Technology Research Institute Investment; and Kunshan Hongtu Hi-tech Venture Capital Management also participated. RiboQuark...
...between RNAi companies Suzhou Ribo Life Sciences Co. Ltd. (Kunshan, China) and Quark Pharmaceuticals Inc. RiboQuark's...
Items per page:
1 - 7 of 7